fda tirzepatide shortage resolved 2025 Lilly's weight-loss drug removed from FDA's list FDA Allows Compounded Tirzepatide During

Air travel with injectable medications is legal and common

MNT had the opportunity to speak with Anton Bilchik, MD, PhD, a surgical oncologist, chief of medicine and director of the Gastrointestinal and Hepatobiliary Program at Providence Saint Johns Cancer Institute in Santa Monica, CA, about this study

avoid screens 1 hour before bed

Semaglutide specifically showed an average weight loss of 9.2 percent in patients with overweight and obesity over 68 weeks in SUSTAIN 12

Payroll accuracy supports smooth employee exits in outplacement programs by ensuring timely settlements, transparent compensation closure, and aligned benefits processing